Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

NCT00231894 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Schizophrenia
Insulin Resistance
Cognitive Impairment

Interventions

DRUG: Pioglitazone
BEHAVIORAL: Life style diet group
OTHER: Placebo

Sponsor

Nathan Kline Institute for Psychiatric Research